Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Galectins play roles in cancer progression, including angiogenesis, metastasis, cell division, and immune evasion.
• Understanding galectin involvement in breast cancer is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To analyze serum concentrations of galectin-1, -3, and -9 in breast cancer patients.
• To correlate galectin levels with tumor characteristics and treatment response.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to quantify serum galectin levels.
• Galectin concentrations were analyzed against patient and tumor characteristics (stage, molecular subtype, receptor expression).

Main Results:

• Galectin-9 was significantly increased in HER2-enriched tumors and decreased in hormone-receptor-positive tumors.
• Galectin-1 levels were significantly elevated in patients undergoing hormonal, immunotherapy, or chemotherapy.
• No significant changes were observed for galectin-3 levels.

Conclusions:

• Galectin levels change during cancer progression and in response to treatment.
• Galectin-1 and -9 may serve as potential biomarkers for breast cancer subtypes and treatment response.
• These findings support further research into galectins as therapeutic targets and diagnostic tools.